 vasculature eye future calcium antagonists use management patients angina pectoris management cardiovascular disorders hypertension calcium antagonists investigation potential protective role atherosclerosis new possibilities therapeutic use development new long-acting tissue-specific calcium antagonists Amlodipine group dihydropyridine-based calcium antagonist pharmacologic profile differs dihydropyridine-based calcium antagonists Differences different pH optimum receptor binding different rates association dissociation differences allosteric interaction diltiazem verapamil binding sites Amlodipine high-cholesterol diet atheroma formation Evidence ability vasculature ability survival stroke-prone hypertensive rats